Literature DB >> 9874443

Economic analysis of expensive technologies: the case of erythropoietin.

J J Griggs, A I Mushlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9874443     DOI： 10.1002/(sici)1097-0142(19981215)83:12<2427::aid-cncr2>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  1 in total

Review 1.  The clinical value of erythropoietin in patients with cancer.

Authors:  Ulrich Dührsen
Journal:  Drugs       Date:  2002       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.